TREA

97412748 - APDUCE

Follow

Information

  • Trademark
  • 97412748
  • Serial Number
    97412748
  • Registration Number
    7172959
  • Filing Date
    May 16, 2022
    3 years ago
  • Registration Date
    September 26, 2023
    2 years ago
  • Transaction Date
    September 26, 2023
    2 years ago
  • Status Date
    September 26, 2023
    2 years ago
  • Published for Opposition Date
    July 11, 2023
    2 years ago
  • Location Date
    September 26, 2023
    2 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MACFARLANE, JAMES W
  • Attorney Docket Number
    ASCNT-20128
    Attorney Name
    Kathryn E. Smith
    Law Office Assigned Location Code
    L40
  • Owners
Information
Mark Drawing Code
4000
Mark Identification
APDUCE
Case File Statements
  • GS0051: Chemical preparations for medical purposes, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs sold in bulk, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; biochemical medicines for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; medicines for human purposes for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemico-pharmaceutical preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; drugs for medical purposes in the nature of prescription apoptosis targeted compounds, next-generation kinase inhibitors and senolytic drugs; biological preparations for medical purposes, namely, biological preparations for the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; chemical preparations for pharmaceutical purposes, namely, for use in the treatment of cancer, tumors, blood-related diseases, infectious diseases, osteoarthritis, age-related diseases, fibrotic diseases, Crohn's disease, and cardiovascular disease; radioactive substances for medical purposes; gases for medical purposes, namely, nitric oxide for medical purposes; chemical conductors for electrocardiograph electrodes; semen for artificial insemination; disinfectants; solutions for contact lenses; media for bacteriological cultures; medicated sweets; dietetic preparations adapted for medical use; depuratives for the body; diagnostic preparations for veterinary purposes; pesticides; sanitary napkins; cotton for medical purposes; dental abrasives; diapers for pets
Case File Event Statements
  • 9/26/2023 - 2 years ago
    23 - NOTICE OF REGISTRATION CONFIRMATION EMAILED Type: NRCC
  • 9/26/2023 - 2 years ago
    22 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 7/11/2023 - 2 years ago
    21 - OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Type: NPUB
  • 7/11/2023 - 2 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 6/21/2023 - 2 years ago
    19 - NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Type: NONP
  • 6/5/2023 - 2 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 5/27/2023 - 2 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 5/27/2023 - 2 years ago
    16 - EXAMINER'S AMENDMENT ENTERED Type: XAEC
  • 5/27/2023 - 2 years ago
    15 - NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Type: GNEN
  • 5/27/2023 - 2 years ago
    14 - EXAMINERS AMENDMENT E-MAILED Type: GNEA
  • 5/27/2023 - 2 years ago
    13 - EXAMINERS AMENDMENT -WRITTEN Type: CNEA
  • 4/24/2023 - 2 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 4/24/2023 - 2 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 4/24/2023 - 2 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 3/12/2023 - 2 years ago
    9 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 3/12/2023 - 2 years ago
    8 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 3/12/2023 - 2 years ago
    7 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/3/2023 - 3 years ago
    6 - ASSIGNED TO EXAMINER Type: DOCK
  • 6/27/2022 - 3 years ago
    5 - PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED Type: AMPX
  • 6/27/2022 - 3 years ago
    4 - ASSIGNED TO LIE Type: ALIE
  • 6/14/2022 - 3 years ago
    3 - TEAS VOLUNTARY AMENDMENT RECEIVED Type: PARI
  • 5/23/2022 - 3 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Type: NWOS
  • 5/19/2022 - 3 years ago
    1 - NEW APPLICATION ENTERED Type: NWAP